A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis

NCT02492321 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis (AC)

Interventions

DRUG: EBI-005
DRUG: Placebo Comparator

Sponsor

Eleven Biotherapeutics